ABSTRACT
The last two decades have seen numerous cell culture -based production facilities come on-line as cell culture-based therapeutics have been approved and launched onto the biopharmaceutical market. One might expect that facility design for cell culture-based manufacturing has become a mature discipline during that period, but this is not entirely the case. New market pressures have forced companies and engineers to adapt and bring projects swiftly while attempting to keep the budgets manageable.
